The Australian and New Zealand journal of psychiatry
-
Aust N Z J Psychiatry · Oct 2012
Letter Case ReportsVarenicline induced psychosis in schizophrenia.
-
Aust N Z J Psychiatry · Mar 2012
Randomized Controlled TrialRepetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
To evaluate the effectiveness of repetitive transcranial magnetic stimulation (rTMS) started with citalopram in first-episode young major depressive patients. ⋯ RTMS accelerated the rapidity of the antidepressant response in first-episode young depressive patients. Our results call for future rTMS studies with larger sample sizes, high intensity of stimuli, and longer duration to draw more definitive conclusions.
-
Aust N Z J Psychiatry · Feb 2012
Randomized Controlled TrialTherapeutic effects of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms.
Cerebrolysin is a nootropic drug with unique neurotrophic activities directly affecting cerebral neurons. This study evaluated the efficacy and safety of cerebrolysin added to risperidone in patients with schizophrenia dominated by negative symptoms. ⋯ Cerebrolysin added to risperidone did not augment the efficacy of risperidone in treating the psychotic symptoms of schizophrenia patients over an 8-week trial. Cerebrolysin at 30 ml per day as an adjunctive treatment was safe and may improve cognitive and memory functions of patients with schizophrenia dominated by negative symptoms.